The historic rise of Viagra has consistently remained a example of pharmaceutical success, but its legacy within the broader industry now triggers questions about potential yields . Generic versions are eroding patent protection , prompting worries that investing in companies heavily reliant to Viagra's former influence could be a problematic strat